{"address1": "1000 Spring Street", "city": "Silver Spring", "state": "MD", "zip": "20910", "country": "United States", "phone": "301 608 9292", "website": "https://www.unither.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland.", "fullTimeEmployees": 1305, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.", "age": 69, "title": "Founder, Chairman & CEO", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 5655205, "exercisedValue": 85384472, "unexercisedValue": 296600992}, {"maxAge": 1, "name": "Mr. Michael I. Benkowitz", "age": 52, "title": "President & COO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 3256268, "exercisedValue": 0, "unexercisedValue": 78112480}, {"maxAge": 1, "name": "Mr. James C. Edgemond", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 2147973, "exercisedValue": 0, "unexercisedValue": 62786368}, {"maxAge": 1, "name": "Mr. Paul A. Mahon J.D.", "age": 60, "title": "Executive VP, General Counsel & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 2441320, "exercisedValue": 15710975, "unexercisedValue": 44611696}, {"maxAge": 1, "name": "Mr. Dewey  Steadman C.F.A.", "title": "Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Holly  Hobson", "title": "Associate Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kevin T. Gray", "title": "Senior Vice President of Strategic Operations & Logistics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Poisson", "age": 56, "title": "Executive VP of Technical Operations", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Leigh  Peterson", "title": "Executive Vice President of Product Development & Xenotransplantation", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gil  Golden", "title": "Senior VP & Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 4, "compensationRisk": 4, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 308.27, "open": 308.17, "dayLow": 303.33, "dayHigh": 311.55, "regularMarketPreviousClose": 308.27, "regularMarketOpen": 308.17, "regularMarketDayLow": 303.33, "regularMarketDayHigh": 311.55, "payoutRatio": 0.0, "beta": 0.639, "trailingPE": 12.454546, "forwardPE": 11.0071745, "volume": 576678, "regularMarketVolume": 576678, "averageVolume": 458715, "averageVolume10days": 478670, "averageDailyVolume10Day": 478670, "bid": 305.58, "ask": 307.83, "bidSize": 2, "askSize": 1, "marketCap": 13782656000, "fiftyTwoWeekLow": 227.75, "fiftyTwoWeekHigh": 417.82, "priceToSalesTrailing12Months": 4.7899685, "fiftyDayAverage": 337.771, "twoHundredDayAverage": 347.0412, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10854248448, "profitMargins": 0.41534, "floatShares": 41324592, "sharesOutstanding": 44912200, "sharesShort": 1826411, "sharesShortPriorMonth": 2065951, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.040700004, "heldPercentInsiders": 0.018339999, "heldPercentInstitutions": 1.0085601, "shortRatio": 2.89, "shortPercentOfFloat": 0.0535, "impliedSharesOutstanding": 44912200, "bookValue": 143.739, "priceToBook": 2.134981, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 0.388, "netIncomeToCommon": 1195100032, "trailingEps": 24.64, "forwardEps": 27.88, "lastSplitFactor": "2:1", "lastSplitDate": 1253664000, "enterpriseToRevenue": 3.772, "enterpriseToEbitda": 7.147, "52WeekChange": 0.3273356, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 306.88, "targetHighPrice": 600.0, "targetLowPrice": 293.0, "targetMeanPrice": 392.21616, "targetMedianPrice": 395.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 3267000064, "totalCashPerShare": 72.742, "ebitda": 1518800000, "totalDebt": 338600000, "quickRatio": 4.805, "currentRatio": 5.248, "totalRevenue": 2877400064, "debtToEquity": 5.255, "revenuePerShare": 63.659, "returnOnAssets": 0.12442, "returnOnEquity": 0.19231, "grossProfits": 2567699968, "freeCashflow": 824724992, "operatingCashflow": 1327100032, "earningsGrowth": 0.421, "revenueGrowth": 0.197, "grossMargins": 0.89237, "ebitdaMargins": 0.52784, "operatingMargins": 0.49178, "financialCurrency": "USD", "symbol": "UTHR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": 24.64, "epsForward": 27.88, "epsCurrentYear": 29.03754, "priceEpsCurrentYear": 10.568388, "fiftyDayAverageChange": -30.890991, "fiftyDayAverageChangePercent": -0.09145543, "twoHundredDayAverageChange": -40.161194, "twoHundredDayAverageChangePercent": -0.11572457, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -0.4508983, "regularMarketPrice": 306.88, "shortName": "United Therapeutics Corporation", "longName": "United Therapeutics Corporation", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 929626200000, "preMarketChange": 2.0, "preMarketChangePercent": 0.6517205, "preMarketPrice": 308.88, "regularMarketChange": -1.3899841, "regularMarketDayRange": "303.33 - 311.55", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 458715, "fiftyTwoWeekLowChange": 79.130005, "fiftyTwoWeekLowChangePercent": 0.3474424, "fiftyTwoWeekRange": "227.75 - 417.82", "fiftyTwoWeekHighChange": -110.94, "fiftyTwoWeekHighChangePercent": -0.26552105, "fiftyTwoWeekChangePercent": 32.73356, "earningsTimestamp": 1740569400, "earningsTimestampStart": 1745929800, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1740578400, "earningsCallTimestampEnd": 1740578400, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743596338, "regularMarketTime": 1743537600, "exchange": "NMS", "messageBoardId": "finmb_36018", "displayName": "United Therapeutics", "trailingPegRatio": null}